Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 30034 entries
Sorted by: Best Match Show Resources per page
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074393
Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 01.

UNLABELLED: In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Assessment of Myocardial Viability, an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate technologies are...

Cite
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(16):1-80
(2010). Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ontario health technology assessment series, 10(16), 1-80.
"Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis." Ontario health technology assessment series vol. 10,16 (2010): 1-80.
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(16):1-80. Epub 2010 Jul 01. PMID: 23074393; PMCID: PMC3377573.
Copy Download .nbib Format: NLM
Nanotechnology: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074489
Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 01.

OBJECTIVE: Due to continuing advances in the development of structures, devices, and systems with a length of about 1 to 100 nanometres (nm) (1 nm is one billionth of a metre), the Medical Advisory Secretariat conducted a horizon scanning...

Cite
Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(19):1-43
(2006). Nanotechnology: an evidence-based analysis. Ontario health technology assessment series, 6(19), 1-43.
"Nanotechnology: an evidence-based analysis." Ontario health technology assessment series vol. 6,19 (2006): 1-43.
Nanotechnology: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(19):1-43. Epub 2006 Nov 01. PMID: 23074489; PMCID: PMC3379172.
Copy Download .nbib Format: NLM
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074389
Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01.

UNLABELLED: In July 2009, the Medical Advisory Secretariat (MAS) began work on Non-Invasive Cardiac Imaging Technologies for the Diagnosis of Coronary Artery Disease (CAD), an evidence-based review of the literature surrounding different cardiac imaging modalities to ensure that appropriate...

Cite
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38
(2010). Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ontario health technology assessment series, 10(12), 1-38.
"Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis." Ontario health technology assessment series vol. 10,12 (2010): 1-38.
Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease: an evidence-based analysis. Ont Health Technol Assess Ser. 2010;10(12):1-38. Epub 2010 Jun 01. PMID: 23074389; PMCID: PMC3377522.
Copy Download .nbib Format: NLM
Functional brain imaging: an evidence-based analysis.

Ontario health technology assessment series

[No authors listed]
PMID: 23074493
Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 01.

OBJECTIVE: The objective of this analysis is to review a spectrum of functional brain imaging technologies to identify whether there are any imaging modalities that are more effective than others for various brain pathology conditions. This evidence-based analysis reviews...

Cite
Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(22):1-79
(2006). Functional brain imaging: an evidence-based analysis. Ontario health technology assessment series, 6(22), 1-79.
"Functional brain imaging: an evidence-based analysis." Ontario health technology assessment series vol. 6,22 (2006): 1-79.
Functional brain imaging: an evidence-based analysis. Ont Health Technol Assess Ser. 2006;6(22):1-79. Epub 2006 Dec 01. PMID: 23074493; PMCID: PMC3379170.
Copy Download .nbib Format: NLM
Teriflunomide for multiple sclerosis.

The Cochrane database of systematic reviews

He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L.
PMID: 27003123
Cochrane Database Syst Rev. 2016 Mar 22;3:CD009882. doi: 10.1002/14651858.CD009882.pub3.

BACKGROUND: This is an update of the Cochrane review "Teriflunomide for multiple sclerosis" (first published in The Cochrane Library 2012, Issue 12).Multiple sclerosis (MS) is a chronic immune-mediated disease of the central nervous system. It is clinically characterized by...

Cite
He D, Zhang C, Zhao X, et al. Teriflunomide for multiple sclerosis. Cochrane Database Syst Rev. 2016;3:CD009882doi: 10.1002/14651858.CD009882.pub3.
He, D., Zhang, C., Zhao, X., Zhang, Y., Dai, Q., Li, Y., & Chu, L. (2016). Teriflunomide for multiple sclerosis. The Cochrane database of systematic reviews, 3CD009882. https://doi.org/10.1002/14651858.CD009882.pub3
He, Dian, et al. "Teriflunomide for multiple sclerosis." The Cochrane database of systematic reviews vol. 3 (2016): CD009882. doi: https://doi.org/10.1002/14651858.CD009882.pub3
He D, Zhang C, Zhao X, Zhang Y, Dai Q, Li Y, Chu L. Teriflunomide for multiple sclerosis. Cochrane Database Syst Rev. 2016 Mar 22;3:CD009882. doi: 10.1002/14651858.CD009882.pub3. PMID: 27003123.
Copy Download .nbib Format: NLM
A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA.

Ultraschall in der Medizin (Stuttgart, Germany : 1980)

Seitz K, Strobel D.
PMID: 27276056
Ultraschall Med. 2016 Jun;37(3):229-32. doi: 10.1055/s-0042-107411. Epub 2016 Jun 08.

The approval of microbubbles with the inert gas sulfur hexafluoride (SF6) and a palmitic acid shell (SonoVue(®), Bracco Geneva, CH) for the diagnostic imaging of liver tumors in adults and children by the FDA in the United States represents...

Cite
Seitz K, Strobel D. Ein Meilenstein: Zulassung von CEUS zur Leberdiagnostik an Erwachsenen und Kindern in den USA. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. Ultraschall Med. 2016;37(3):229-32doi: 10.1055/s-0042-107411.
Seitz, K., & Strobel, D. (2016). Ein Meilenstein: Zulassung von CEUS zur Leberdiagnostik an Erwachsenen und Kindern in den USA. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. Ultraschall in der Medizin (Stuttgart, Germany : 1980), 37(3), 229-32. https://doi.org/10.1055/s-0042-107411
Seitz, K, and Strobel, D. "Ein Meilenstein: Zulassung von CEUS zur Leberdiagnostik an Erwachsenen und Kindern in den USA." A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. Ultraschall in der Medizin (Stuttgart, Germany : 1980) vol. 37,3 (2016): 229-32. doi: https://doi.org/10.1055/s-0042-107411
Seitz K, Strobel D. Ein Meilenstein: Zulassung von CEUS zur Leberdiagnostik an Erwachsenen und Kindern in den USA. A Milestone: Approval of CEUS for Diagnostic Liver Imaging in Adults and Children in the USA. Ultraschall Med. 2016 Jun;37(3):229-32. doi: 10.1055/s-0042-107411. Epub 2016 Jun 08. PMID: 27276056.
Copy Download .nbib Format: NLM
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy.

Health technology assessment (Winchester, England)

Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM.
PMID: 25265259
Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590.

BACKGROUND: Cardiac magnetic resonance imaging (CMR) is increasingly used to assess patients for myocardial viability prior to revascularisation. This is important to ensure that only those likely to benefit are subjected to the risk of revascularisation.OBJECTIVES: To assess current...

Cite
Campbell F, Thokala P, Uttley LC, et al. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Health Technol Assess. 2014;18(59):1-120doi: 10.3310/hta18590.
Campbell, F., Thokala, P., Uttley, L. C., Sutton, A., Sutton, A. J., Al-Mohammad, A., & Thomas, S. M. (2014). Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Health technology assessment (Winchester, England), 18(59), 1-120. https://doi.org/10.3310/hta18590
Campbell, Fiona, et al. "Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy." Health technology assessment (Winchester, England) vol. 18,59 (2014): 1-120. doi: https://doi.org/10.3310/hta18590
Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A, Thomas SM. Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Health Technol Assess. 2014 Sep;18(59):1-120. doi: 10.3310/hta18590. PMID: 25265259; PMCID: PMC4781084.
Copy Download .nbib Format: NLM
Automatic MRI-based Three-dimensional Models of Hip Cartilage Provide Improved Morphologic and Biochemical Analysis.

Clinical orthopaedics and related research

Schmaranzer F, Helfenstein R, Zeng G, Lerch TD, Novais EN, Wylie JD, Kim YJ, Siebenrock KA, Tannast M, Zheng G.
PMID: 30998632
Clin Orthop Relat Res. 2019 May;477(5):1036-1052. doi: 10.1097/CORR.0000000000000755.

BACKGROUND: The time-consuming and user-dependent postprocessing of biochemical cartilage MRI has limited the use of delayed gadolinium-enhanced MRI of cartilage (dGEMRIC). An automated analysis of biochemical three-dimensional (3-D) images could deliver a more time-efficient and objective evaluation of cartilage...

Cite
Schmaranzer F, Helfenstein R, Zeng G, et al. Automatic MRI-based Three-dimensional Models of Hip Cartilage Provide Improved Morphologic and Biochemical Analysis. Clin Orthop Relat Res. 2019;477(5):1036-1052doi: 10.1097/CORR.0000000000000755.
Schmaranzer, F., Helfenstein, R., Zeng, G., Lerch, T. D., Novais, E. N., Wylie, J. D., Kim, Y. J., Siebenrock, K. A., Tannast, M., & Zheng, G. (2019). Automatic MRI-based Three-dimensional Models of Hip Cartilage Provide Improved Morphologic and Biochemical Analysis. Clinical orthopaedics and related research, 477(5), 1036-1052. https://doi.org/10.1097/CORR.0000000000000755
Schmaranzer, Florian, et al. "Automatic MRI-based Three-dimensional Models of Hip Cartilage Provide Improved Morphologic and Biochemical Analysis." Clinical orthopaedics and related research vol. 477,5 (2019): 1036-1052. doi: https://doi.org/10.1097/CORR.0000000000000755
Schmaranzer F, Helfenstein R, Zeng G, Lerch TD, Novais EN, Wylie JD, Kim YJ, Siebenrock KA, Tannast M, Zheng G. Automatic MRI-based Three-dimensional Models of Hip Cartilage Provide Improved Morphologic and Biochemical Analysis. Clin Orthop Relat Res. 2019 May;477(5):1036-1052. doi: 10.1097/CORR.0000000000000755. PMID: 30998632; PMCID: PMC6494340.
Copy Download .nbib Format: NLM
Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).

European heart journal. Cardiovascular Imaging

Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, Popescu BA, Underwood R, Habib G, Zamorano JL, Saraiva RM, Sabino EC, Botoni FA, Barbosa MM, Barros MVL, Falqueto E, Simões MV, Schmidt A, Rochitte CE, Rocha MOC, Ribeiro ALP, Lancellotti P.
PMID: 29029074
Eur Heart J Cardiovasc Imaging. 2018 Apr 01;19(4):459-460n. doi: 10.1093/ehjci/jex154.

AIMS: To develop a document by Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI) to review and summarize the most recent evidences about the non-invasive assessment of patients with Chagas disease, with the intent...

Cite
Nunes MCP, Badano LP, Marin-Neto JA, et al. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018;19(4):459-460ndoi: 10.1093/ehjci/jex154.
Nunes, M. C. P., Badano, L. P., Marin-Neto, J. A., Edvardsen, T., Fernández-Golfín, C., Bucciarelli-Ducci, C., Popescu, B. A., Underwood, R., Habib, G., Zamorano, J. L., Saraiva, R. M., Sabino, E. C., Botoni, F. A., Barbosa, M. M., Barros, M. V. L., Falqueto, E., Simões, M. V., Schmidt, A., Rochitte, C. E., Rocha, M. O. C., Ribeiro, A. L. P., & Lancellotti, P. (2018). Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). European heart journal. Cardiovascular Imaging, 19(4), 459-460n. https://doi.org/10.1093/ehjci/jex154
Nunes, Maria Carmo P, et al. "Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI)." European heart journal. Cardiovascular Imaging vol. 19,4 (2018): 459-460n. doi: https://doi.org/10.1093/ehjci/jex154
Nunes MCP, Badano LP, Marin-Neto JA, Edvardsen T, Fernández-Golfín C, Bucciarelli-Ducci C, Popescu BA, Underwood R, Habib G, Zamorano JL, Saraiva RM, Sabino EC, Botoni FA, Barbosa MM, Barros MVL, Falqueto E, Simões MV, Schmidt A, Rochitte CE, Rocha MOC, Ribeiro ALP, Lancellotti P. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI). Eur Heart J Cardiovasc Imaging. 2018 Apr 01;19(4):459-460n. doi: 10.1093/ehjci/jex154. PMID: 29029074.
Copy Download .nbib Format: NLM
Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System.

Asian journal of neurosurgery

Thavara BD, Kidangan GS, Rajagopalawarrier B.
PMID: 31143261
Asian J Neurosurg. 2019 Apr-Jun;14(2):453-460. doi: 10.4103/ajns.AJNS_254_18.

BACKGROUND: Conventionally, intradural spinal tumor excision requires longer skin incision, bilateral subperiosteal muscle stripping, and total laminectomy, thereby decreasing the stability of the spine and increasing the morbidity. Minimally invasive surgery (MIS) for intradural spinal tumor excision preserves the...

Cite
Thavara BD, Kidangan GS, Rajagopalawarrier B. Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian J Neurosurg. 2019;14(2):453-460doi: 10.4103/ajns.AJNS_254_18.
Thavara, B. D., Kidangan, G. S., & Rajagopalawarrier, B. (2019). Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian journal of neurosurgery, 14(2), 453-460. https://doi.org/10.4103/ajns.AJNS_254_18
Thavara, Binoy Damodar, et al. "Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System." Asian journal of neurosurgery vol. 14,2 (2019): 453-460. doi: https://doi.org/10.4103/ajns.AJNS_254_18
Thavara BD, Kidangan GS, Rajagopalawarrier B. Analysis of the Surgical Technique and Outcome of the Thoracic and Lumbar Intradural Spinal Tumor Excision Using Minimally Invasive Tubular Retractor System. Asian J Neurosurg. 2019 Apr-Jun;14(2):453-460. doi: 10.4103/ajns.AJNS_254_18. PMID: 31143261; PMCID: PMC6516036.
Copy Download .nbib Format: NLM
Rituximab for relapsing-remitting multiple sclerosis.

The Cochrane database of systematic reviews

He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H.
PMID: 24310855
Cochrane Database Syst Rev. 2013 Dec 06;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3.

BACKGROUND: This is an update of the Cochrane review "Rituximab for relapsing-remitting multiple sclerosis" (first published in The Cochrane Library 2011, Issue 12).More than 80% of individuals with multiple sclerosis (MS) experience a relapsing-remitting disease course. Approximately 10 years...

Cite
He D, Guo R, Zhang F, et al. Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev. 2013;(12):CD009130doi: 10.1002/14651858.CD009130.pub3.
He, D., Guo, R., Zhang, F., Zhang, C., Dong, S., & Zhou, H. (2013). Rituximab for relapsing-remitting multiple sclerosis. The Cochrane database of systematic reviews, (12), CD009130. https://doi.org/10.1002/14651858.CD009130.pub3
He, Dian, et al. "Rituximab for relapsing-remitting multiple sclerosis." The Cochrane database of systematic reviews vol. ,12 (2013): CD009130. doi: https://doi.org/10.1002/14651858.CD009130.pub3
He D, Guo R, Zhang F, Zhang C, Dong S, Zhou H. Rituximab for relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev. 2013 Dec 06;(12):CD009130. doi: 10.1002/14651858.CD009130.pub3. PMID: 24310855.
Copy Download .nbib Format: NLM
Glutamate, T cells and multiple sclerosis.

Journal of neural transmission (Vienna, Austria : 1996)

Levite M.
PMID: 28236206
J Neural Transm (Vienna). 2017 Jul;124(7):775-798. doi: 10.1007/s00702-016-1661-z. Epub 2017 Feb 24.

Glutamate is the major excitatory neurotransmitter in the nervous system, where it induces multiple beneficial and essential effects. Yet, excess glutamate, evident in a kaleidoscope of acute and chronic pathologies, is absolutely catastrophic, since it induces excitotoxicity and massive...

Cite
Levite M. Glutamate, T cells and multiple sclerosis. J Neural Transm (Vienna). 2017;124(7):775-798doi: 10.1007/s00702-016-1661-z.
Levite, M. (2017). Glutamate, T cells and multiple sclerosis. Journal of neural transmission (Vienna, Austria : 1996), 124(7), 775-798. https://doi.org/10.1007/s00702-016-1661-z
Levite, Mia. "Glutamate, T cells and multiple sclerosis." Journal of neural transmission (Vienna, Austria : 1996) vol. 124,7 (2017): 775-798. doi: https://doi.org/10.1007/s00702-016-1661-z
Levite M. Glutamate, T cells and multiple sclerosis. J Neural Transm (Vienna). 2017 Jul;124(7):775-798. doi: 10.1007/s00702-016-1661-z. Epub 2017 Feb 24. PMID: 28236206.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 30034 entries